Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cytokines and heart failure].

G Baumgarten1, C Grohe, A Hoeft

  • 1Klinik für Anästhesiologie und spezilae Intensivmedizin, Rheinischen Friedrich-Wilhelms-Universität, Bonn. Georg.Baumgarten@ukb.uni-bonn.de

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|April 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PET/CT-guided management of immune checkpoint blockade and multi-modal profiling following treatment in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study.

Endocrine-related cancer·2024
Same author

Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer-final results of the EUCROSS trial.

ESMO open·2024
Same author

A new large pantherine and a sabre-toothed cat (Mammalia, Carnivora, Felidae) from the late Miocene hominoid-bearing Khorat sand pits, Nakhon Ratchasima Province, northeastern Thailand.

Die Naturwissenschaften·2023
Same author

The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report.

ESMO open·2022
Same author

Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66].

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Cytokines play a key role in chronic heart failure (CHF) pathogenesis, impacting left ventricular function. Anti-inflammatory strategies targeting cytokines are crucial for future CHF treatment development.

Area of Science:

  • Cardiology
  • Immunology
  • Pharmacology

Context:

  • Chronic heart failure (CHF) is a leading cause of mortality and morbidity.
  • Existing hypotheses on CHF pathogenesis lack comprehensive explanations.
  • Cytokines are implicated in CHF development and progression.

Purpose:

  • To review experimental and clinical evidence on cytokines in CHF.
  • To discuss pharmacologic interventions modulating cytokine expression.
  • To highlight the potential of anti-inflammatory approaches for CHF treatment.

Summary:

  • Cytokines are expressed during CHF and significantly depress left ventricular function.
  • ACE-inhibitors, beta-blockers, and angiotensin type 1 antagonists can modulate cytokine expression.

Related Experiment Videos

  • Research indicates a strong link between cytokine activity and CHF characteristics.

    • Impact:

    • Findings underscore the importance of understanding cytokine roles in CHF.
    • Suggests that anti-inflammatory therapies represent a promising avenue for CHF management.
    • Emphasizes the need for further research into cytokine-targeted treatments for heart failure.